Oncology Therapeutics and Drug Development

Prof. Giuseppe Murdaca, MD, PhD, is an Associate Professor of Internal Medicine at the University of Genoa, Italy. He obtained his MD degree with honors from the University of Genoa and later specialized in Allergology and Clinical Immunology. He also holds a PhD in Sciences and Space Engineering. His academic career includes extensive experience in clinical medicine, immunology, and translational research. Prof. Murdaca serves as an evaluation expert for ANVUR and is an editorial board member and associate editor for several high-impact international journals. He has authored over 200 peer-reviewed publications and actively contributes to international scientific research and education.

• Immunodeficiency
• Autoimmune diseases
• Neuro-endocrino-immunology
• Pharmacogenomics
• Vaccines and autoimmune diseases
• Soluble immune molecules

• Associate Editor and Editorial Board Member for multiple international journals including Frontiers in Immunology, Biomedicines, International Journal of Molecular Sciences, Disease Markers, and Vaccines

• AVA Evaluation Expert for accreditation of university study programs (ANVUR, Italy)

• Member of:

  • Italian Society of Immunology, Clinical Immunology and Allergy

  • Italian Society of Internal Medicine

  • Italian Society of Experimental Biology

  • European Academy of Allergy and Clinical Immunology (EAACI)

• Editor of scientific e-books

• Regular reviewer for high-impact international journals

• Speaker at national and international scientific conferences

1. Caserta S., Cancemi G., Murdaca G., et al. The Effects of Cancer Immunotherapy on Fertility: Focus on Hematological Malignancies. Biomedicines, 2024.
2. Allegra A., Murdaca G., Mirabile G., Gangemi S. Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients. Biomedicines, 2023.
3. Caserta S., Gangemi S., Murdaca G., Allegra A. Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility. International Journal of Molecular Sciences, 2023.
4. Murdaca G., Allegra A., Paladin F., et al. Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma. International Journal of Molecular Sciences, 2021.
5. Boutros A., Schiavi C., Cecchi F., et al., Murdaca G. Immune-related toxicity during adjuvant treatment with BRAF plus MEK inhibitors. Frontiers in Immunology, 2020.
6. Fenoglio D., Traverso P., Parodi A., et al., Murdaca G. A Multi-Peptide, Dual-Adjuvant Telomerase Vaccine (GX301) in Prostate and Renal Cancer. Cancer Immunology, Immunotherapy, 2013.
7. Murdaca G., Spanò F., Puppo F. Effects of TNF-α inhibitors upon VEGF mechanisms: implications for cancer and angiogenesis. Immunotherapy, 2013.
8. Murdaca G., Colombo B.M., Puppo F. Emerging biological drugs in immune-mediated diseases: relevance to oncology. Autoimmunity Reviews, 2011.
9. Carbone R.G., Negrini S., Murdaca G., Puppo F. Stem Cell Therapy for the Treatment of Chronic Ischemic Heart Disease: translational implications. Cardiology and Cardiovascular Medicine, 2021.
10. Carbone R.G., Negrini S., Murdaca G., Fontana V., Puppo F. Stem Cells Treatment in Chronic Ischemic Heart Disease. American Journal of Stem Cells, 2023.
11. Allegra A., Murdaca G., Gammeri L., Gangemi S. Alarmins and MicroRNAs: therapeutic implications in cancer and inflammatory diseases. International Journal of Molecular Sciences, 2023.
12. Murdaca G., Paladin F., Gangemi S. Immunosenescence and chronic inflammation: relevance for cancer progression and therapy. Frontiers in Bioscience, 2023.
13. Sciaccotta R., Murdaca G., Caserta S., et al. Circular RNAs: new perspectives in immune-mediated and neoplastic diseases. Biomedicines, 2023.
14. Isola S., Murdaca G., et al. Artificial Intelligence and exposome analysis in chronic and neoplastic diseases. Informatics, 2024.
15. Murdaca G., Greco M., Gangemi S. Cytokine storm pathways and immune modulation: implications for cancer immunotherapy. Biomedicines, 2021.